Your browser doesn't support javascript.
loading
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.
Mesci, Aruz; Lucien, Fabrice; Huang, Xiaoyong; Wang, Eric H; Shin, David; Meringer, Michelle; Hoey, Christianne; Ray, Jessica; Boutros, Paul C; Leong, Hon S; Liu, Stanley K.
Afiliação
  • Mesci A; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Lucien F; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
  • Huang X; Mayo Clinic Cancer Centre, Rochester, MN, USA.
  • Wang EH; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Shin D; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Meringer M; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Hoey C; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Ray J; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Boutros PC; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Leong HS; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Liu SK; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
J Transl Med ; 17(1): 125, 2019 04 15.
Article em En | MEDLINE | ID: mdl-30987640
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Trombospondinas Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Trombospondinas Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá